Legislative record

A 3621STATE · New JerseyIn Committee

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Latest action: Introduced in the Assembly, Referred to Assembly Health Committee

Voted 2/12/2024

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

Action history

  1. 2/12/2024Introduced in the Assembly, Referred to Assembly Health Committee